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Lyophilized protein formulations must be reconstituted back into solution prior to patient administration
and in this regard long reconstitution times are not ideal. The factors that govern reconstitution time
remain poorly understood. The aim of this research was to understand the influence of the lyophilization
cooling profile (including annealing) on the resulting cake structure and reconstitution time. Three pro-
tein formulations (BSA 50 mg/ml, BSA 200 mg/ml and IgG1 40 mg/ml, all in 7% w/v sucrose) were inves-
tigated after cooling at either 0.5 C/min, or quench cooling with liquid nitrogen with/without annealing.
Significantly longer reconstitution times were observed for the lower protein concentration formulations
following quench cool. Porosity measurements found concomitant increases in the surface area of the
porous cake structure but a reduction in total pore volume. We propose that slow reconstitution results
from either closed pores or small pores impeding the penetration of water into the lyophilized cake.
 2015 The Authors. Published by Elsevier B.V. This is an open access articleunder the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
To improve the shelf-life and stability of a protein formulation,
water can be removed to slow the chemical and physical degrada-
tion pathways. The most common method of drying is by
lyophilization [1].
Prior to administration the lyophilized product must be recon-
stituted back into solution, however, for some protein formulations
this can be time consuming. For instance, two lyophilized anti-
venom products for pit viper snakebites were found to take 40
and >90 min to reconstitute [2]. In addition, higher concentration
monoclonal antibody formulations may require 20–40 min for
reconstitution [3]. The reconstitution procedure can also differ
depending on the product, which can add further complexity to
the administration process. For example, after the addition of a
diluent, a product may require swirling every five minutes [3], or
may be left undisturbed for 30 min to fully reconstitute [4].
A commonly used approach for improving the dissolution time
of poorly soluble small drug molecules is by increasing the surface
area of the product, for instance by formulating as a solid disper-
sion [5], or using size reduction techniques [6]. However, recentresearch has suggested that surface area is not a predominant fac-
tor in reducing the reconstitution times of lyophilized protein for-
mulations. One such study [7], using BSA and a monoclonal
antibody as model proteins, found that controlled ice nucleation
gave improvements on reconstitution time and proposed this
was attributed to the formation of larger pores. However, surface
area, which is related to pore size, was not found to be a critical
factor for improving reconstitution time in a study investigating
multiple parameters such as protein concentration and excipient
choice within an Fc-fusion protein formulation [8].
Despite the increasing therapeutic importance of biopharma-
ceuticals, there have been limited studies on the factors contribut-
ing towards long reconstitution time. Therefore, the motivation of
the present study was to gain a greater understanding of how two
related factors – pore size and surface area – influence the recon-
stitution time of lyophilized protein formulations. As cooling rate,
nucleation temperature, degree of supercooling and heat treat-
ment of a lyophilization cycle can all affect the ice crystal morphol-
ogy [9] (and therefore the formulation parameters of interest), the
present contribution has focussed on the influence of the
lyophilization cooling rate on the resulting cake structure.
Furthermore, as previous studies have shown either an increase
[10], or a decrease [11,12] in reconstitution time of annealed com-
pared to non-annealed samples, the impact of annealing on recon-
stitution time was also investigated.
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2.1. Materials
BSA (molecular weight 66 kDa), sucrose and histidine buffer
salts were all purchased from Sigma–Aldrich. BSA was prepared
in a 25 mM histidine buffer solution, pH 6.0, with 7% w/v sucrose
to give final concentrations of 50 mg/ml and 200 mg/ml.
Monoclonal IgG1 (molecular weight 150 kDa), hereafter referred
to as ‘mAb1’, was kindly provided by MedImmune Ltd. at 40 mg/
ml in a 25 mM histidine solution, pH 6.0, with 7% sucrose. The
three formulations were filtered (0.22 lm) and the protein concen-
trations were confirmed by UV absorbance at 280 nm (NanoDrop,
Thermo Fisher Scientific).2.2. Methods
2.2.1. Lyophilization
The three formulations were lyophilized using a 1 mlfill volume
in 13 mm Schott Type I clear tubular 3ml glass injection vials
(West Pharmaceutical Services)with Daikyo D777-1 13 mm single
vent lyo-stopper(West Pharmaceutical Services). Vials were placed
within a custommade stainless steel fence which was used to keep
vials in the centre of the freeze dryer. Two freeze dryers were used:
a Virtis Advantage Plus two shelf freeze dryer (SP Scientific) for
cooling profiles without an annealing step and a Virtis Advantage
one shelf freeze dryer (SP Scientific) for cooling profiles with an
annealing step. Thermocouples, calibrated before use, were placed
into one BSA 50 mg/ml formulation in the centre of the freeze
dryer for each cycle. The four cooling profiles can be seen in
Table 1, after which the pressure was reduced to 100 mTorr and
the temperature was raised to 20 C and held for 41.5 h to allow
primary drying. The shelf temperature was then ramped at 0.1 C/
min to 20 C for secondary drying and held at this temperature for
12 h at 200 mTorr.2.2.2. Karl Fisher moisture determination
After each lyophilization cycle, three vials of each BSA formula-
tion were removed. The residual water content was determined by
injecting 2 ml of methanol into sealed vials which was then mixed
in a vortex for 15 min to extract the moisture and analysed by a
Mettler Toledo C30 Coulometric Karl Fischer Titrator. The mAb1
formulation was not used for this analysis due to the limited num-
ber of samples lyophilized.2.2.3. Scanning Electron Microscopy (SEM)
Samples were prepared for analysis using SEM stubs in a dry
argon box. To alleviate compression of the cake during preparation,
a sharp scalpel was used to cut the lyophilized material to expose
an internal cross section. A Leica EM SCD005 sputter coater (Leica
Microsystems) was used to coat samples in gold for 120 s atTable 1
A description of the protocol followed for each lyophilization cooling profile.
Cooling profile
0.5 C/min Samples were cooled at 0.5 C/min to 40 C and held
0.5 C/min + annealed Samples were cooled at 0.5 C/min to 40 C and held
for four hours after which the shelf temperature was l
Quench cooled Samples were immersed for approximately 2 min in liq
40 C. This shelf temperature was then maintained f
Quench cooled + annealed Samples were immersed for approximately 2 min in liq
40 C. This shelf temperature was then maintained f
hours before lowering it over 30 min to 40 C and ho26 mAmps. A JEOL JSM 6060LV SEM (JEOL Ltd.) was used with an
accelerating voltage of 16 kV.2.2.4. Brunauer, Emmett & Teller (BET) specific surface area
measurements
BET adsorption theory [13] was used to calculate the specific
surface area of the lyophilized formulations. Nitrogen isotherms
were acquired using an Automated Surface Area Porosity
Analyser (ASAP2420, Micromeritics Instrument Corporation) at
195.8 C using a relative pressure range of 0.01–0.99. Prior to
analysis samples (weight 100–150 mg) were gently broken using
a spatula and were then degassed under vacuum for 3 h at ambient
temperature. Helium gas was used to calculate warm (ambient)
and cold free space. BET specific surface area (SSA) was calculated
using the adsorption range of 0.1–0.4 relative pressure providing
positive BET constants.2.2.5. Mercury Intrusion Porosimetry (MIP)
Mercury intrusion porosimetry was performed using an
AutoPore IV Mercury Porosimeter (Micromeritics Instrument
Corporation) on samples used for BET analysis with measurements
taken between 1 and 3600 psi. A contact angle of 130 was used
with mercury density adjusted according to room temperature.
Samples were weighed after MIP and observed for signs of com-
pression. Again, due to the limited number of mAb1 samples, only
the BSA formulations were used for this analysis. Bulk density was
calculated using a pressure of 0.51 psi.2.2.6. Reconstitution time
The volume of water required for reconstitution was calculated
based on the amount of water removed from each formulation (i.e.
total weight less the amount of solids). This value was then
rounded to the nearest 0.1 ml, based on the graduation of syringes
found in a hospital setting. For BSA 50 mg/ml and mAb1 40 mg/ml
formulations, 0.9 ml of water was used for reconstitution and for
BSA 200 mg/ml 0.8 ml of water was used. Prior to reconstitution,
the samples requiring different reconstitution volumes were sepa-
rated and the formulation labels blinded to randomize the cooling
profiles and maintain a level of objectivity. Samples were then
reconstituted using a syringe with the water low aimed at the
inside wall of the vial. The vial was then swirled for approximately
five seconds to ensure the sides and bottom of the lyophilized cake
were wetted. The vial was then left upright on a counter without
further agitation until fully dissolved. This static procedure was
chosen in order to minimize variability in the reconstitution time
determination. The reconstitution time was defined as the time
needed to dissolve all visible solids in the vial from the point of
water injection. Six vials of each formulation were reconstituted.
Statistical analyses were performed using a one-way analysis of
variance with Bonferroni correction.for two hours.
for two hours. The temperature was then ramped over 30 min to 5 C and held
owered over 30 min to 40 C and held for a further 30 min
uid nitrogen and then placed onto the freeze dryer shelf, which was pre-cooled to
or two hours
uid nitrogen and then placed onto the freeze dryer shelf, which was precooled to
or two hours after which it was ramped over 30 min to 5 C and held for four
lding for a further 30 min
Fig. 1. The appearance of the different protein formulations after lyophilization.
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3.1. Lyophilized cake appearance
After lyophilization, representative cakes were evaluated and
found to be amorphous. On visual inspection, small scale uniform
cake shrinkage and cracking were observed for all samples and,
to a greater extent, with quench cooled only samples in which
the cakes were no longer in contact with the sides of the vial
(Fig. 1). This was likely due to a high amount of unfrozen amor-
phous water remaining in the formulation prior to desorption dur-
ing secondary drying. Macro-collapse, in which there is significant
shrinkage and loss of structural integrity of the cake, was not evi-
dent in the samples.3.2. Reconstitution time
The reconstitution times of the three lyophilized formulations
are shown in Fig. 2. The change in protein secondary structure
was also evaluated by IR spectroscopy second derivative analysis
(data not shown). For all formulations at least 96% conservation
in secondary structure was found in the reconstituted formula-
tions, when compared to the solution state, prior to lyophilization.
The reconstitution times of BSA 50 mg/ml and mAb1 formulations
were found to be significantly longer in samples lyophilized by
quench cooling. Increasing the BSA concentration from 50 mg/ml
to 200 mg/ml led to longer reconstitution times of up to approxi-
mately 40 min, although no statistically significant differences
were observed between the different cooling profiles.
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Two distinct pore geometries were created by the different
cooling profiles: interconnected spherical shaped pores from
0.5 C/min and annealing profiles, and cylindrical pores after
quench cooling without an annealing step (Fig. 3). The spherical
shaped pores likely reflect ice crystal growth through a global
supercooling process, where ice can form stable hexagonal den-
drites [14,15]. During annealing, ice crystals can grow through
re-crystallization processes such as Ostwald ripening where larger
ice crystals grow at the expense of smaller crystals, the increased
molecular mobility of which is provided by the higher tempera-
tures during annealing [12]. The lamellar structure observed for
quench cooled samples is the likely result of ice growth through
directional solidification where, due to the fast freezing rate, spher-
ulites (ice spears) form without side branches [16]. The change
from cylindrical to spherical shaped pores during annealing of fast
cooled samples has previously been reported [12].
3.4. Surface area and moisture measurements
The BET specific surface area (SSA) and residual moisture con-
tents (BSA formulations only) for the lyophilized samples can be
seen in Fig. 4. Quench cooled samples were found to have the lar-
gest BET SSA at approximately 3 m2/g. The increased surface area
of samples prepared by quench cooling compared to those frozen
slowly is consistent with other literature [17]. Samples that were
lyophilized with an annealing step in the cooling profile wereFig. 2. The reconstitution times of the three lyophilized formulations using four diff
*(p < 0.05), **(p < 0.01) and ***(p < 0.001). Please note the difference in y-axis scale. Each bo
Dashed lines show the minimum and maximum reconstitution times. Outliers, defined a
shown as circles.found to have the lowest BET SSA, which is consistent with SEM
images that showed the appearance of larger pores in annealed
samples. The residual moisture contents, measured by Karl Fisher
titration, were all found to be less than 1%, which is a suitable level
for a lyophilized protein formulation [18]. The residual moisture
content for the BSA 50 mg/ml formulation was found to be lower
after quench cooling compared to the other cooling profiles. This
is likely due to the larger SSA which allows faster water desorption
rates resulting in less residual moisture within the lyophilized cake
[19].
3.5. Porosimetry measurements
The pressure which allows mercury, a non-wetting probe, to
intrude into a porous sample can be used to determine the inner
pore aperture size through the relationship described by the
Washburn equation [20]. For each BSA formulation and cooling
profile, three samples were analysed (Fig. 5). The pore size distri-
butions of these three samples appear in good agreement with
each other suggesting that the cake structure is reproducible
within the batch, depending on the initial formulation and process-
ing parameters.
One broad pore size distribution was observed between 10 and
50 lm for BSA 50 mg/ml lyophilized at a 0.5 C/min cooling rate.
With the addition of an annealing step, a trimodal pore distribution
was observed after both 0.5 C/min and quench cooling rates. A
bimodal size distribution was observed with BSA 50 mg/ml after
quench cooling: the first between 1 and 8 lm and the seconderent cooling profiles, (n = 6). Statistically significant differences are denoted by
x plot represents the interquartile range with the median as the thick horizontal line.
s being greater than 1.5 times the distance from the lower and upper quartiles are
Fig. 3. The appearance (by SEM) of the different protein formulations after lyophilization.
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20 lm). Only one pore size distribution can be distinguished for
the 200 mg/ml BSA formulation where, after 0.5 C/min and quench
cooled profiles, pore sizes appear less than 5 lm in diameter. After
annealing the pore sizes increase to approximately 10–20 lm.
In Figs. 6 and 7 the bulk density and total pore volume, derived
from MIP experiments, have been shown, respectively. The bulk
density of samples was measured by applying a pressure that
allowed mercury to surround the sample without penetrating into
the pores (0.51 psi). The resulting sample volume therefore
includes both solid material and pore spaces. The total pore vol-
ume of the samples was determined using the volume of mercury
intruded into the sample (up to a pressure of 3600 psi). Although
bulk density and total pore volume have been shown separately,
their multiplication can be used to describe the porosity of the
sample. No significant differences were observed in bulk density
between the different cooling profiles of the lyophilized BSA
200 mg/ml formulation. For the BSA 50 mg/ml cakes, a significantly
higher bulk density and lower total pore volume were observed
after quench cooling compared to the annealed samples.Fig. 4. The BET specific surface area of lyophilized formulations and the corre-
sponding residual moisture contents (shown for BSA formulations only) (n = 3,
mean ± s.d.).4. Discussion
The key result from this study is that significantly longer recon-
stitution times were observed for the quench cooled BSA 50 mg/ml
Fig. 5. The log differential intrusion of mercury into the two BSA formulations. Three vials of each formulation were analysed and are shown separately. Please note the
different scale for quench cooled samples.
Fig. 6. The bulk density of lyophilized BSA formulations (n = 3, mean ± s.d.).
Statistically significant differences are denoted by *(p < 0.05).
Fig. 7. The total pore volume of BSA formulations (n = 3, mean ± s.d.). Statistically
significant differences are denoted by *(p < 0.05) and ***(p < 0.001).
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These results are consistent with other recent research [7,8,21]
and we also conclude that surface area was not a predominant fac-
tor in determining lyophilized cake reconstitution time.
For the BSA 200 mg/ml formulation, altering the lyophilization
cooling profile was not found to significantly affect the reconstitu-
tion time of the lyophilized cakes. The observed increase in recon-
stitution time compared to BSA 50 mg/ml and mAb1 formulations,
may be explained by concentration effects altering the solution vis-
cosity. At high concentrations, self-association of the protein can
lead to large increases in its viscosity [22], thus retarding
diffusion-controlled reconstitution. As vials were left undisturbed
after initial wetting in this study, the reconstitution process may
also have been further prolonged by allowing the establishment
of high concentration and high viscosity regions within the cake.
Although viscosity and protein self-association measurements
were outside the scope of this work, which focussed on surface
area and porosimetry measurements, it is acknowledged that these
factors would need to be taken into account in more detailed mod-
els of fluid flow and diffusion processes underpinning the reconsti-
tution processes.
For the lower concentration protein formulations investigated
in this study, two important structural features are believed to
have lead to the reconstitution times observed, namely the pres-
ence of closed pores and the size of pores. In other studies
[23,24], the openness and connectivity of pores has been found
to be important for decreasing vapour transit resistance during
lyophilization. Conversely, a more open network of pores could
also allow better penetration of the diluent into the lyophilized
cake.
The loss of total pore volume with quench cooled BSA 50 mg/ml
cakes may be partially caused by closed pores in the lyophilized
material. The higher bulk density in these samples compared to
the other cooling profiles also suggests that there is some collapse
of the cake structure [25], which is consistent with the greater
degree of volumetric shrinkage observed with the quench cooled
samples. In addition to volumetric shrinkage, high amorphous
water content during secondary drying may lead to changes in
the microstructure of the cake which could alter the reconstitution
process, although this has yet to be corroborated in the literature.
The poor intrusion of mercury into samples with closed pores may
also correspond with poor penetration of water into the cake, thus
prolonging reconstitution times.
Two pore size distributions were observed with quench cooled
BSA 50 mg/ml samples. From the SEM images (Fig. 3), the smaller
pore size appears consistent with the width of the cylindrical pores
observed. It is possible that the size distribution of larger pores
may have resulted from breakage of the pore walls, leading to
wider apertures. After annealing of the BSA 50 mg/ml sample, a tri-
modal pore size distribution was evident after 0.5 C/min and
quench cooling rates. It is possible that the different size distribu-
tions result from ice crystals, which vary in size between the bot-
tom and top of the vial [26]. Ostwald ripening, which can occur
during annealing, could also lead to an increase in the mean pore
size and changes in the pore size distribution [12]. However, it is
likely that these mechanisms would lead to a continuous, rather
than a trimodal, distribution of pore sizes. Discrete pore size distri-
butions have not previously been reported within this research
field and suggest that the annealing process during lyophilization
may be more complex than previously thought.
Rather than the number of pore size distributions, it is likely
that the size of the pores (and the volume that they occupy in
the sample), would affect the reconstitution time. Both Darcy’s
Law, which describes the permeability of a fluid through a porous
material [27], and the Hagen–Poiseuille equation, which relates
flow rate through a cylinder, (Eq. (1)), describe permeability/flowrate as being directly proportional to the pore size in a power-
law relationship:
Q ¼ pR
4DP
8gL
ð1Þ
where Q is the volumetric flow rate, R is the radius of the cylinder
that has a length of L, DP is the change in pressure across the cylin-
der and g is the viscosity of the medium. The relationship between
flow rate and pore size described by the Hagen–Poiseuille equation
can have important consequences when comparing samples with
different pore diameters of, for example: 2, 20 and 50 lm (which
are similar to those observed in Fig. 5 for BSA 50 mg/ml quench
cooled, cooled at 0.5 C/min and annealed samples, respectively).
Through simple calculation, a 10,000-fold increase in flow rate is
expected if pore diameter is increased from 2 to 20 lm. However,
only a 40-fold increase occurs between pores that are 20 and
50 lm in diameter. The longer reconstitution times that were
observed with the BSA 50 mg/ml quench cooled samples may be
explained by this theory, as approximately half of the pore volume
was associated with pores that were approximately 2 lm in diam-
eter. It is interesting to consider that if a power-law relationship
does exist between pore size and reconstitution time, then there
may also be a critical pore size below which reconstitution time will
be prolonged by slow water penetration into the lyophilized cake.5. Conclusions
The lyophilization cooling rate, but not annealing, was found to
affect the reconstitution time of two lyophilized protein formula-
tions. However, the significance of this appears also to be depen-
dent on the protein concentration. This work is consistent with
other recent studies and has found that an increase in specific sur-
face area of the formulation did not decrease reconstitution time.
Rather, the shorter reconstitution times for the BSA 50 mg/ml
and mAb1 formulations were likely due to the more open network
of larger spherical pores (as observed in SEM images), compared to
quench cooled cakes with narrower cylindrical pores. Further con-
sideration should be given to the power-law relationships describ-
ing fluid flow through porous networks, and a possible ‘‘cut-off” in
pore size below which the increase in reconstitution time becomes
impractical for lyophilized formulations.Acknowledgements
This study was supported by the Targeted Therapeutics Centre
for Doctoral Training (University of Nottingham) which is jointly
funded by AstraZeneca and the Engineering and Physical Sciences
Research Council (Grant EP/D501849/1).References
[1] S.D. Allison, T.W. Randolph, M.C. Manning, K. Middleton, A. Davis, J.F.
Carpenter, Effects of drying methods and additives on structure and function
of actin: mechanisms of dehydration-induced damage and its inhibition, Arch.
Biochem. Biophys. 358 (1) (1998) 171–181.
[2] R.E. Hill, G.M. Bogdan, R.C. Dart, Time to reconstitution: purified Fab
antivenom vs. unpurified IgG antivenom, Toxicon 39 (5) (2001) 729–731.
[3] How to Prepare & Administer XOLAIR, Genentech, Inc. and Novartis
Pharmaceuticals Corp ration, 2014, Available from: <http://www.xolair.com/
hcp/how-to-prepare-and-administer-xolair.html#accordionTab2>, (accessed
25.04.14).
[4] Highlights of Prescribing Information, UCB, Inc.; 2013, Available from: <www.
cimzia.com/assets/pdf/Prescribing_Information.pdf>, (accessed 18.01.15).
[5] C. Leuner, J. Dressman, Improving drug solubility for oral delivery using solid
dispersions, Eur. J. Pharm. Biopharm. 50 (1) (2000) 47–60.
[6] E. Merisko-Liversidge, G.G. Liversidge, E.R. Cooper, Nanosizing: a formulation
approach for poorly-water-soluble compounds, Eur. J. Pharm. Sci. 18 (2) (2003)
113–120.
254 K.E. Beech et al. / European Journal of Pharmaceutics and Biopharmaceutics 96 (2015) 247–254[7] R. Geidobler, I. Konrad, G. Winter, Can controlled ice nucleation improve
freeze-drying of highly-concentrated protein formulations?, J Pharm. Sci. 102
(11) (2013) 3915–3919.
[8] W. Cao, S. Krishnan, M.S. Ricci, L.Y. Shih, D. Liu, J.H. Gu, et al., Rational design of
lyophilized high concentration protein formulations-mitigating the challenge
of slow reconstitution with multidisciplinary strategies, Eur. J. Pharm.
Biopharm. 85 (2) (2013) 287–293.
[9] B. Chang, S. Patro, Freeze-drying process development for protein
pharmaceuticals, in: H. Costantino, M. Pikal (Eds.), Lyophilization of
Biopharmaceuticals, American Association of Pharmaceutical Scientists,
Arlington, VA, 2004, pp. 113–138.
[10] S. Webb, J. Cleland, J. Carpenter, T. Randolph, Effects of annealing lyophilized
and spray-lyophilized formulations of recombinant human interferon-
gamma, J. Pharm. Sci. 92 (4) (2003) 715–729.
[11] J. Blue, H. Yoder, Successful lyophilization development of protein
therapeutics, Am. Pharm. Rev. 12 (2009) 90–96.
[12] J. Searles, J. Carpenter, T. Randolph, Annealing to optimize the primary drying
rate, reduce freezing-induced drying rate heterogeneity, and determine Tg0 in
pharmaceutical lyophilization, J. Pharm. Sci. 90 (7) (2001) 872–887.
[13] S. Brunauer, P. Emmett, E. Teller, Adsorption of gases in multimolecular layers,
J. Am. Chem. Soc. 60 (2) (1938) 309–319.
[14] J.C. Kasper, W. Friess, The freezing step in lyophilization: physico-chemical
fundamentals, freezing methods and consequences on process performance
and quality attributes of biopharmaceuticals, Eur. J. Pharm. Biopharm. 78 (2)
(2011) 248–263.
[15] T.A. Felix Franks, Essential physics of low temperature and freezing, Freeze-
drying of Pharmaceuticals and Biopharmaceuticals: Principles and Practice,
The Royal Society of Chemistry, Cambridge, UK, 2007, pp. 28–53.
[16] G. Petzold, J.M. Aguilera, Ice morphology: fundamentals and technological
applications in foods, Food Biophys. 4 (4) (2009) 378–396.[17] J. Sarciaux, S. Mansour, M. Hageman, S. Nail, Effects of buffer composition and
processing conditions on aggregation of bovine IgG during freeze-drying, J.
Pharm. Sci. 88 (12) (1999) 1354–1361.
[18] W. Wang, Lyophilization and development of solid protein pharmaceuticals,
Int. J. Pharm. 203 (1–2) (2000) 1–60.
[19] M. Pikal, S. Shah, M. Roy, R. Putman, The secondary drying stage of freeze-
drying – drying kinetics as a function of temperature and chamber pressure,
Int. J. Pharm. 60 (3) (1990) 203–217.
[20] E.W. Washburn, The dynamics of capillary flow, Phys. Rev. 17 (1921) 273–283.
[21] D. Awotwe-Otoo, C. Agarabi, E.K. Read, S. Lute, K.A. Brorson, M.A. Khan, et al.,
Impactof controlled icenucleationonprocess performanceandquality attributes
of a lyophilized monoclonal antibody, Int. J. Pharm. 450 (1–2) (2013) 70–78.
[22] S.J. Shire, Z. Shahrokh, J. Liu, Challenges in the development of high protein
concentration formulations, J. Pharm. Sci. 93 (6) (2004) 1390–1402.
[23] D. Overcashier, T. Patapoff, C. Hsu, Lyophilization of protein formulations in
vials: investigation of the relationship between resistance to vapor flow during
primary drying and small-scale product collapse, J. Pharm. Sci. 88 (7) (1999)
688–695.
[24] R.E. Johnson, M.E. Oldroyd, S.S. Ahmed, H. Gieseler, L.M. Lewis, Use of
manometric temperature measurements (MTM) to characterize the freeze-
drying behavior of amorphous protein formulations, J. Pharm. Sci. 99 (6)
(2010) 2863–2873.
[25] M.K. Krokida, V.T. Karathanos, Z.B. Maroulis, Effect of freeze-drying conditions
on shrinkage and porosity of dehydrated agricultural products, J. Food Eng. 35
(4) (1998) 369–380.
[26] A. Hottot, S. Vessot, J. Andrieu, Freeze drying of pharmaceuticals in vials:
Influence of freezing protocol and sample configuration on ice morphology
and freeze-dried cake texture, Chem. Eng. Process. 46 (7) (2007) 666–674.
[27] G.O. Brown, Henry Darcy and the making of a law, Water Resour. Res. 38 (7)
(2002) 11-1–11-12.
